Capabilities

Acquisition of Bayer AG’s Interventional business

Boston Scientific Corporation
2014

Our attoneys were antitrust counsel for Boston Scientific Corporation in its US$415 million acquisition of Bayer AG’s Interventional business. 

Email Disclaimer